Bill Ashton

Track

Insider profile

Currently holds positions in Spectrum Pharmaceuticals Inc and Recro Pharma Inc

Positions

Position Company Period
Independent Chairman of the Board Spectrum Pharmaceuticals Inc June 19, 2019 -
Independent Director Recro Pharma Inc Jan. 1, 2009 -
Independent Director Spectrum Pharmaceuticals Inc Feb. 23, 2018 - June 19, 2019
Independent Director Sellas Life Sciences Group Inc April 26, 2013 - Dec. 29, 2017
Independent Director Sucampo Pharmaceuticals Inc Oct. 15, 2009 - May 29, 2015
Bill Ashton's trades of Recro Pharma Inc's stock


• Purchase • Sale • Planned purchase • Planned sale Net purchase Net sale Buy signal Sell signal Earnings
Abbreviations B: Buy, S: Sell, PP: Planned purchase, PlS: Planned sale, PrS: Proposed sale, O: Option / Other
Transaction date
Purchase
Price
294.82
Quantity 25,643 -21.1%
Value US$1,149,484
Notification date Transaction date Company B/S Transaction type Nb. shares
Price
Value 		Number of shares Price Value Details
2023-08-28 2023-08-28
B Purchase
25,643 -21.1%
294.82
US$1,149,484 		25,643 -21.1% 294.82 US$1,149,484
2022-06-22 2022-06-21
PlS Planned sale
81,351 +37.7%
302.03
US$4,840,677 		81,351 +37.7% 302.03 US$4,840,677
2020-06-23 2020-06-22
PlS Planned sale
85,929 -36.9%
300.69
US$415,858 		85,929 -36.9% 300.69 US$415,858
2019-06-21 2019-06-20
PlS Planned sale
1,667 -20.0%
8.50
US$14,170 		1,667 -20.0% 8.50 US$14,170
2019-06-21 2019-06-19
PlS Planned sale
5,000 -37.5%
8.59
US$42,950 		5,000 -37.5% 8.59 US$42,950